Flinton Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$17.8M Buy
92,140
+4,930
+6% +$946K 0.55% 36
2019
Q2
$16.1M Buy
87,210
+31,246
+56% +$5.59M 0.51% 40
2019
Q1
$10.6M Buy
55,964
+13,498
+32% +$2.58M 0.35% 56
2018
Q4
$8.27M Buy
42,466
+9,826
+30% +$1.92M 0.31% 71
2018
Q3
$6.77M Sell
32,640
-5,916
-15% -$1.17M 0.21% 106
2018
Q2
$7.12M Sell
38,556
-23,290
-38% -$4.12M 0.23% 95
2018
Q1
$10.5M Sell
61,846
-8,942
-13% -$1.64M 0.35% 65
2017
Q4
$12.3M Buy
70,788
+9,418
+15% +$1.67M 0.42% 56
2017
Q3
$11.4M Sell
61,370
-3,400
-5% -$602K 0.41% 64
2017
Q2
$11.2M Buy
64,770
+11,220
+21% +$1.82M 0.41% 57
2017
Q1
$8.79M Buy
53,550
+9,792
+22% +$1.63M 0.34% 59
2016
Q4
$6.4M Buy
+43,758
New +$6.59M 0.28% 71

Other funds holding AMGN

Flinton Capital Management's AMGN Position: Q3 2019 in Review

Flinton Capital Management increased its Amgen (AMGN) stake by 5.7% in Q3 2019, buying an estimated $946K and bringing the position to 92,140 shares worth $17.8M. The position accounts for 0.55% of the portfolio, ranked #36.

Flinton Capital Management first reported a position in AMGN in Q4 2016 and has held it in 12 quarters since. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Flinton Capital Management held 92,140 shares of Amgen worth $17.8M as of Q3 2019.
  • Flinton Capital Management bought 4,930 Amgen shares in Q3 2019, an estimated $946K.
  • Amgen made up 0.55% of Flinton Capital Management's portfolio in Q3 2019, its #36 holding.
  • Flinton Capital Management first reported a position in Amgen in Q4 2016 and has held it in 12 quarters since.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.